Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.

Source:http://linkedlifedata.com/resource/pubmed/id/16870693

Download in:

View as

General Info

PMID
16870693